Form: C-AR

Annual Report

May 1, 2023

Documents

schemaVersion:

Form C: Filer Information

Filer CIK:
0001958777 
Filer CCC:
XXXXXXXX 
Period:

12-31-2022 
Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

Submission Contact Information

Name:
 
Phone Number:
 
Contact E-Mail Address:
 

Form C: Issuer Information

Issuer Information

Name of Issuer:

FibroBiologics, Inc. 

Legal Status of Issuer:

Form:

Corporation 
Jurisdiction of Incorporation/Organization:

DELAWARE  
Date of Incorporation/Organization:

12-14-2021 

Physical Address of Issuer:

Address 1:

455 E. Medical Center Blvd Suite 300 
City:

Houston 
State/Country:

TEXAS  
Mailing Zip/Postal Code:

77598 
Website of Issuer:

www.fibrobiologics.com 
Is there a Co-issuer? Radio button not checked Yes Radio button checked No

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:

7.00 
Total Assets Most Recent Fiscal Year-end:

4824000.00 
Total Assets Prior Fiscal Year-end:

468000.00 
Cash and Cash Equivalents Most Recent Fiscal Year-end:

2266000.00 
Cash and Cash Equivalents Prior Fiscal Year-end:

407000.00 
Accounts Receivable Most Recent Fiscal Year-end:

0.00 
Accounts Receivable Prior Fiscal Year-end:

0.00 
Short-term Debt Most Recent Fiscal Year-end:

7073000.00 
Short-term Debt Prior Fiscal Year-end:

1758000.00 
Long-term Debt Most Recent Fiscal Year-end:

1747000.00 
Long-term Debt Prior Fiscal Year-end:

0.00 
Revenue/Sales Most Recent Fiscal Year-end:

0.00 
Revenue/Sales Prior Fiscal Year-end:

0.00 
Cost of Goods Sold Most Recent Fiscal Year-end:

0.00 
Cost of Goods Sold Prior Fiscal Year-end:

0.00 
Taxes Paid Most Recent Fiscal Year-end:

0.00 
Taxes Paid Prior Fiscal Year-end:

0.00 
Net Income Most Recent Fiscal Year-end:

-5121000.00 
Net Income Prior Fiscal Year-end:

-1582000.00 

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:

FibroBiologics, Inc. 
Signature:

/s/ Peter O'Heeron 
Title:

Chairman/Founder/CEO 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Mark Andersen 
Title:

CFO 
Date:

05-01-2023